Jared Seehafer
Senior Advisor, FDA. On 1 show, 1 appearance. The Shows tab opens the full record on each.
founderexecutiveinvestor@seehafer ↗enzyme.com ↗
Jared Seehafer co-founded and served as CEO of Enzyme Corporation, a regulatory and quality management software platform acquired by Greenlight Guru. Following the acquisition, he transitioned into public service as a senior policy advisor at the FDA.
1shows
1appearances
12statements
1resolved
1supported
0contradicted
100%fully supported
Everything Jared Seehafer said on any show that made the record, most notable first. Each card names its show and opens the statement there.
Seehafer: Medtech failures often stem from market delays, not product quality
“What I found is being an engineer that it would take forever to get your products on the market, and it was very expensive, and you saw a lot of failures that weren't necessarily related to whether the product was any good or not, or did what it said”
Enzyme experiences zero customer churn unless a client gets acquired
“Well, so, for the nature of our business is such that we don't really see churn. Churn for us is, is a customer getting bought or acquired, and so.”
Seehafer: Enzyme aims to radically automate life science regulatory documentation
“What we're trying to do at Enzyme is to use software to radically simplify the amount of human labor that goes into making all of this documentation that the government needs to say yes or no.”
Enzyme's annual contract values range from five to seven figures
“So it's anywhere depending on company size from a five figure to a seven figure a year type of situation.”
Seehafer: Enzyme has 21 production customers across startups and enterprises
“We've got 21 companies that are using the platform in production of various sizes, everything from sort of, you know, product teams, the large organizations, enterprise organizations, to like I said, kind of a garage startup.”
Seehafer: SF cost of living favors building quasi-remote teams
“It's just that the cost of living situation has sort of made it advantageous to really try to make a quasi remote organization from the ground up.”
Enzyme will increase burn to build an enterprise sales force
“No, I mean, so where we are going to be burning money is going to be, as we sort of drive from you know, transitioning the company is something that's serving these small organizations to larger enterprises, going to necessitate an enterprise sales force. And …”
Seehafer: Life science startups spend hundreds of thousands on regulatory compliance
“You're talking of spending hundreds of thousands of dollars, in addition to the development cost of your product, for your product to ever see the light of day.”
Seehafer: Enzyme landed its first customer from an impromptu 15-minute demo
“All basically sort of when the space, 15 minutes had the demo, the product was a total mess, but it was doing enough that they found it valuable and we've been working with it ever since.”
One line per show, most statements first. The link opens Jared's full record on that show: the calibration, argument clarity, speaking style and every statement made there.
| Show | Role there | Eps | Statements | Record | |
|---|---|---|---|---|---|
 TOP FOUNDERSLEDGER | Senior Advisor, FDA | 1 | 12 | 100% 1/1 | full record on Top Founders → |